Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.
This week’s Research Roundup highlights the prediction of oncologic outcomes in Renal cell carcinoma after surgery.
This week’s Research Roundup highlights cryptogenic cirrhosis and sitosterolemia, a treatable disease if identified but fatal if missed.
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.
This week’s Research Roundup highlights pathways impacted by genomic alterations in pulmonary carcinoid tumors.
This week’s Research Roundup highlights improving immune-vascular crosstalk for cancer immunotherapy.
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer─even after 30 years of stability, according to findings of a study by Mayo Clinic researchers published in the New England Journal of Medicine.
This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.
A study by Mayo Clinic researchers found that most patients with suspected spinal cord inflammation of unknown cause have an alternative, specific diagnosis. The research is published in Neurology, the medical journal of the American Academy of Neurology.
This week’s Research Roundup highlights how cardiac troponin is released from injured myocardium.
This week’s Research Roundup highlights multifaceted Fanconi anemia signaling.
This week’s Research Roundup highlights global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction.
Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.